These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35909186)

  • 1. A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria.
    Igarashi A; Yuasa A; Yonemoto N; Kamei K; LoPresti M; Murofushi T; Ikeda S
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1729-1751. PubMed ID: 35909186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.
    D'Angiolella LS; Cortesi PA; Lafranconi A; Micale M; Mangano S; Cesana G; Mantovani LG
    Pharmacoeconomics; 2018 May; 36(5):567-589. PubMed ID: 29441473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders.
    Yuasa A; Yonemoto N; Kamei K; Murofushi T; LoPresti M; Taneja A; Horgan J; Ikeda S
    Adv Ther; 2022 Dec; 39(12):5327-5350. PubMed ID: 36205907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.
    Fasseeh AN; Elezbawy B; Korra N; Tannira M; Dalle H; Aderian S; Abaza S; Kaló Z
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2653-2668. PubMed ID: 36197589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life.
    Grob JJ; Revuz J; Ortonne JP; Auquier P; Lorette G
    Br J Dermatol; 2005 Feb; 152(2):289-95. PubMed ID: 15727641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economic analyses of psoriasis management: a systematic literature search.
    Gutknecht M; Krensel M; Augustin M
    Arch Dermatol Res; 2016 Nov; 308(9):601-616. PubMed ID: 27435415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
    Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
    Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria.
    Pascal C; Maucort-Boulch D; Gilibert S; Bottigioli D; Verdu V; Jaulent C; Hacard F; Bérard F; Nicolas JF; Nosbaum A
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2339-2345. PubMed ID: 32119144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review.
    Puig L; Fernández-Freire LR; Burgos-Pol R; Gomez I; Peral C; Gomez S; Rebollo Laserna FJ
    Dermatol Ther (Heidelb); 2019 Sep; 9(3):479-496. PubMed ID: 31062222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?
    Löfvendahl S; Petersson IF; Theander E; Svensson Å; Zhou C; Steen Carlsson K
    J Rheumatol; 2016 Mar; 43(3):640-7. PubMed ID: 26773111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M; Epstein D; Bojke L; Yang H; Craig D; Fonseca T; Myers L; Bruce I; Chalmers R; Bujkiewicz S; Lai M; Cooper N; Abrams K; Spiegelhalter D; Sutton A; Sculpher M; Woolacott N
    Health Technol Assess; 2011 Feb; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: The role of systemic treatments as a possible trigger.
    Paolino G; Di Nicola MR; Brianti P; Bianchi VG; Mercuri SR
    Dermatol Ther; 2022 Nov; 35(11):e15814. PubMed ID: 36088634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.
    Lopes N; Dias LLS; Azulay-Abulafia L; Oyafuso LKM; Suarez MV; Fabricio L; Kobata CM; Cestari T; Gontijo B; Sabbag CY; Antonio JR; Romiti R; Pertel PC
    Adv Ther; 2019 Oct; 36(10):2849-2865. PubMed ID: 31432463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
    Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
    Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of moderate and severe psoriasis.
    Claes C; Kulp W; Greiner W; von der Schulenburg JM; Werfel T
    GMS Health Technol Assess; 2006 Apr; 2():Doc07. PubMed ID: 21289958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
    Yuasa A; Yonemoto N; LoPresti M; Ikeda S
    Pharmacoeconomics; 2021 Jan; 39(1):81-97. PubMed ID: 33230613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines.
    Mauskopf J; Samuel M; McBride D; Mallya UG; Feldman SR
    Pharmacoeconomics; 2014 Apr; 32(4):395-409. PubMed ID: 24469676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of health economic analyses in atopic dermatitis: how diverse is the literature?
    Gutknecht M; Reinert R; Augustin M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):127-145. PubMed ID: 30590976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.